Company Description LGC’s Diagnostics and Genomics (D&G) Business Unit encompasses a number of entities focussed on the development and manufacture of quality solutions and component materials for the extended life sciences industry. We partner with in
Scientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transformative medicines which address unmet patient needs